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Abstract
Background: Cellular membranes are crucial host components utilized by positive-strand RNA viruses for
replication of their genomes. Published studies have suggested that the synthesis and distribution of membrane
lipids are particularly important for the assembly and function of positive-strand RNA virus replication complexes.
However, the impact of specific lipid metabolism pathways in this process have not been well defined, nor have
potential changes in lipid expression associated with positive-strand RNA virus replication been examined in detail.
Results: In this study we used parallel and complementary global and targeted approaches to examine the impact
of lipid metabolism on the replication of the well-studied model alphanodavirus Flock House virus (FHV). We found
that FHV RNA replication in cultured Drosophila S2 cells stimulated the transcriptional upregulation of several lipid
metabolism genes, and was also associated with increased phosphatidylcholine accumulation with preferential
increases in lipid molecules with longer and unsaturated acyl chains. Furthermore, targeted RNA interference-
mediated downregulation of candidate glycerophospholipid metabolism genes revealed a functional role of several
genes in virus replication. In particular, we found that downregulation of Cct1 or Cct2, which encode essential
enzymes for phosphatidylcholine biosynthesis, suppressed FHV RNA replication.
Conclusion: These results indicate that glycerophospholipid metabolism, and in particular phosphatidylcholine
biosynthesis, plays an important role in FHV RNA replication. Furthermore, they provide a framework in which to
further explore the impact of specific steps in lipid metabolism on FHV replication, and potentially identify novel
cellular targets for the development of drugs to inhibit positive-strand RNA viruses.
Background
The relatively small genome of most positive-strand
RNA viruses compels these pathogens to use cellular
machinery to complete their replication cycles. The
search for these “host factors” utilized by positive-strand
RNA viruses is at the forefront of virology research, due
in part to the possibility that cellular proteins or pro-
cesses may represent more stable drug targets or pro-
vide broader antiviral activity when disrupted [1]. One
diverse host factor that has been identified as crucial for
positive-strand RNA virus replication are intracellular
membranes [2-5]. Although viruses that contain a lipid
envelope as a structural component clearly utilize cellu-
lar membranes to form infectious virions, all positive-
strand RNA viruses, both enveloped and non-enveloped,
also depend on host intracellular membranes for the
assembly and function of the viral RNA replication com-
plexes essential for genome amplification. The precise
functions of cellular membranes in this process have not
been fully defined, but may include: (i) serving as struc-
tural scaffolds for replication complex targeting and
assembly; (ii) protecting viral RNA or replication
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or (iii) providing essential protein or lipid cofactors for
optimal viral enzymatic activities. These proposed func-
tions are not mutually exclusive, and it is likely that cel-
lular membranes and their constituent components play
multiple roles in viral RNA replication.
To investigate the role of host factors in viral RNA
replication we use Flock House virus (FHV), a versatile
model virus and natural insect pathogen that assembles
robust functional RNA replication complexes in yeast
[6,7], plant [8], mammalian [9], nematode [10], and
insect cells [11]. This broad array of eukaryotic hosts
that support FHV RNA replication suggests that cellular
factors utilized by this virus are widely conserved. The
FHV genome is bipartite, with two positive-sense RNA
segments copackaged into a non-enveloped virion (Fig.
1A). The larger 3.1-kb genomic segment, RNA1,
encodes protein A, the FHV RNA-dependent RNA poly-
merase, which is the only viral protein required for
functional RNA replication complex assembly. FHV
assembles its RNA replication complexes on mitochon-
drial outer membranes [7,11], where they are targeted
and anchored in part via an amino-proximal transmem-
brane domain present within protein A [12]. During
RNA replication FHV produces a 0.4-kb subgenomic
segment, RNA3, which encodes the RNA interference
(RNAi) suppressor protein B2. This viral counterdefense
protein is required for maximal viral RNA synthesis in
cells with an active RNAi antiviral system [10,13]. Since
subgenomic RNA3, and hence protein B2, are produced
only during active RNA replication, they serve as conve-
nient and quantitative markers for FHV RNA replication
complex activity. The smaller 1.4-kb genomic segment,
RNA2, encodes the structural capsid protein precursor.
The FHV capsid protein is required for infectious virion
production but is dispensable for viral RNA replication,
and therefore engineered self-replicating viral RNAs,
termed replicons, need only contain FHV RNA1
(Figs. 1B and 1C).
Apart from the membrane localization of its viral
RNA replication complexes, additional lines of evidence
point to the importance of membranes, and in particular
lipids, in FHV replication. Protein A is a lipid-binding
protein with particular affinity for specific anionic phos-
pholipids [14], which may mediate in part the protein
A-membrane interactions required for replication com-
plex assembly. FHV RNA replication induces dramatic
mitochondrial membrane rearrangements [7,11,15,16],
reminiscent of structures seen with other positive-strand
RNA viruses [2]. The fatty acid synthetase inhibitor cer-
ulenin disrupts FHV RNA replication [17], consistent
with the activity of this inhibitor on other positive-
FHV RNA1 cDNA
δRz MT pS2F1
m7G
m7G
m7G
A
B
RNA1 (3100 nt)
RNA2 (1400 nt)
sgRNA3
(400 nt)
PtnA (RdRp)
Capsid (structural)
PtnB2 (RNAi
suppressor)
BlaR
*
RNA pol II 
transcription
(+)RNA1 
sgRNA3 synthesis
C
Nucleus
Infection Replicon
RNA2 replication
(+)RNA2 
FHV pS2F1
PtnA
synthesis
Capsid expression
Encapsidation
RNA1 replication
PtnB expression
Figure 1 FHV genome and replicon schematics and replication strategy. (A) FHV genome is bipartite with 3.1 kb (RNA1) and 1.4 kb (RNA2)
segments, and during replication a 0.4 kb subgenomic (sg) segment (RNA3) is also produced. RNA1 encodes protein A, the FHV RNA-dependent
RNA polymerase (RdRp), RNA2 encodes the FHV structural protein precursor, and RNA3 encodes the RNA interference (RNAi) suppressor protein
B2 (PtnB2). (B) Schematic of pS2F1, a metallothionein (MT) promoter-driven plasmid that expresses an FHV RNA1 replicon. Authentic viral 5’ and
3’ termini are generated by precise transcription initiation and a hepatitis δ ribozyme (δRz), respectively. The asterisk indicates the position of the
frame-shifting mutation in pS2F1fs that results in the production of a truncated and non-functional RNA polymerase. Expression of the
blasticidin-resistance gene (Bla
R) used for selection is controlled by the copia transposon LTR constitutive promoter. (C) Strategy for FHV genome
replication initiated by infection or replicon transfection. The intracellular events indicated in bold type are common for FHV RNA replication
initiated via either infection or replicon induction.
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Page 2 of 16strand RNA viruses [18,19]. Finally, FHV RNA replica-
tion complex activity in isolated membrane fractions
analyzed in vitro is disrupted by certain detergents [20],
and can be augmented by the addition of exogenous
phospholipids [21]. These results all suggest a central
role of cellular lipid metabolism in FHV RNA replica-
tion complex assembly and function. However, none of
them provide direct evidence for a functional impact of
specific lipid metabolism pathways on FHV RNA repli-
cation within intact cells.
In this report, we use complementary transcriptomic,
lipidomic, and targeted functional genetic analyses to
specifically examine the role of lipids in FHV RNA repli-
cation in cultured Drosophila cells. We demonstrate that
FHV infection or replicon expression upregulates the
transcription of a distinct set of cellular genes, several of
which are involved in lipid metabolism. Furthermore,
FHV RNA replication induces global changes in cellular
phospholipid content, and in particular phosphatidyl-
choline (PC), and pharmacologic or genetic disruption
of PC synthesis within cells inhibits FHV RNA
replication.
Results
FHV RNA replication induces transcriptional upregulation
of lipid metabolism genes in Drosophila S2 cells
We examined the transcriptional responses of Droso-
phila S2 cells to FHV RNA replication using genome-
wide microarray analyses. To focus on cellular responses
related to RNA replication rather than those associated
with other steps in the viral life cycle, such as virion
attachment, entry, uncoating, encapsidation, and virion
release, we conducted parallel analyses of cells either
infected with FHV or transfected with an RNA1 repli-
con-expression plasmid. The RNA1 segment of the FHV
genome encodes the viral RNA-dependent RNA poly-
merase (Fig. 1A) and is the only genome segment
required for RNA replication (Fig. 1C). Thus, FHV RNA
replication can be initiated in S2 cells by the introduc-
tion of a self-replicating RNA1 via the inducible plasmid
pS2F1 (Figs. 1B and 1C) [22]. To maximize the number
of S2 cells expressing the replicon, we first generated
stable cell lines containing pS2F1 or a control plasmid
(pS2F1fs, see Fig. 1B legend) containing a translation-
defective RNA1 segment. Although there was a low
level of baseline FHV RNA replication in pS2F1-expres-
sing cells due to leaky metallothionein promoter activity,
induction with copper sulfate resulted in a dramatic
increase in subgenomic RNA3 and protein B2 accumu-
lation, indicative of highly active viral RNA replication
complexes (data not shown).
We analyzed transcript levels from three independent
experiments with either FHV-infected cells or cells
expressing an RNA1 replicon, and identified cellular
genes whose transcription was significantly up- or
downregulated in response to these stimuli. We identi-
fied 790 genes that were significantly upregulated and
392 genes that were significantly downregulated in
FHV-infected S2 cells (Additional File 1), and 305 genes
that were significantly upregulated in pS2F1-expressing
cells (Additional File 2). There were no significantly
downregulated genes in pS2F1-expressing cells. Full
details regarding the molecular functions, biological pro-
cesses, and cellular components for these genes are pro-
vided in the additional files. We further analyzed these
datasets for transcripts that were upregulated with both
stimuli and identified 73 co-regulated genes, which
encoded proteins involved in numerous aspects of cellu-
lar physiology, such as metabolism, defense responses,
and signal transduction (Table 1 and Additional File 3).
Based in part on the well recognized importance of cel-
lular membranes in positive-strand RNA virus replica-
tion [3-5], we focused on those genes that encoded
proteins with known or hypothesized roles in lipid
metabolism. We found that infection with FHV upregu-
lated eight lipid metabolism-associated genes, whereas
RNA1 replicon expression upregulated thirteen lipid
metabolism-associated genes (Fig. 2A). Four of these
genes were upregulated in both datasets, including Cct1
and Cct2, which encode CTP:phosphocholine cytidylyl-
transferases. These enzymes are essential for the salvage
pathway of PC synthesis but have non-overlapping func-
tions in Drosophila cells [23-26]. We validated both
Cct1 and Cct2 mRNA upregulation by RT-PCR after
FHV infection (Fig. 2B) and RNA1 replicon expression
(Fig. 2C). These results demonstrated that FHV RNA
replication in Drosophila S2 cells was associated with
distinct alterations in cellular gene transcription, includ-
ing the transcription of genes associated with lipid
metabolism.
FHV RNA replication alters phospholipid levels in
Drosophila S2 cells
The conclusion that FHV RNA replication was asso-
ciated with transcriptional upregulation of lipid metabo-
lism genes predicts that quantifiable changes in lipid
constituents should also be observed, particularly with
respect to PC content. To examine this prediction we
measured total PC levels in S2 cells after infection or
replicon expression using a modified phospholipase D-
based biochemical assay [27] (Fig. 3A). As a control for
these experiments we used cells treated with 1-hexade-
cylphosphorylcholine (miltefosine), which is a specific
CTP:phosphocholine cytidylyltransferase inhibitor [28].
S2 cells infected with FHV had a 35% increase in total
PC levels, whereas treatment with miltefosine reduced
PC levels by 40% (Fig. 3A, left graph). Furthermore,
although baseline PC levels in stably transfected cells
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sion of an FHV RNA1 replicon was associated with a
70% increase in PC levels (Fig. 3A, right graph). These
results indicated that FHV RNA replication-associated
transcriptional upregulation of PC biosynthetic genes in
S2 cells (Fig. 2) was associated with a concomitant
increase in cellular PC levels.
To evaluate potential lipid changes associated with
FHV replication in S2 cells in more detail we used elec-
trospray ionization tandem mass spectrometry (ESI-MS/
Table 1 Drosophila genes co-upregulated in S2 cells
either infected with FHV or expressing an RNA1 replicon.
Biological Process Gene
Symbol
Gene Name
Carbohydrate
metabolism
cenB1A Centaurin b1A
CG12582 -
Heme metabolism Alas Aminolevulinate synthase
l(3)02640 Lethal (3) 02649
Lipid metabolism Cct1 CTP:phosphocholine
cytidylyltransferase 1
Cct2 CTP:phosphocholine
cytidylyltransferase 2
CG3902 -
Lip4 Lipase 4
Protein metabolism CalpC Calpain C
CG1340 -
CG4266 -
CG18557 -
dream dream
pUf68 Poly U binding factor 68 kDa
stv Starvin
Metabolism, other CG3168 -
CG9886 -
CG10137 -
CG17807 -
Defense response cactin cactin
dos Daughter of sevenless
Eip75B Ecdysone-induced protein 75B
PGRP-LA Peptidoglycan recognition protein
LA
Rel Relish
Sp7 Serine protease 7
Traf-like TNF-receptor-associated factor-like
Signal transduction CG6954 -
CG11534 -
CG12091 -
Dgp-1 Dgp-1
drongo drongo
Ptp61f Protein tyrosine phosphatase 61F
RhoGAP18B RhoGAP18B
Socs36E Suppressor of cytokine signalling
at 36E
sra Sarah
Transcription CG16903 -
Ets21C Ets at 21C
Nvy Nervy
Rab10 Rab-protein 10
Cytoskeletal
organization
Insc Inscuteable
WASp WASp
Table 1: Drosophila genes co-upregulated in S2 cells
either infected with FHV or expressing an RNA1 replicon.
(Continued)
Transport CG4726 -
Tamo tamo
DNA synthesis DNApol-iota DNApol-iota
Stress response Hsp23 Heat shock protein 23
Cell development Foi Fear-of-intimacy
Ubiquitin cycle CG9153 -
Unknown CG1529 -
CG4036 -
CG4281 -
CG5118 -
CG5399 -
CG6701 -
CG6762 -
CG7326 -
CG7457 -
CG7967 -
CG8620 -
CG9796 -
CG12022 -
CG12084 -
CG13117 -
CG13917 -
CG13926 -
CG14642 -
CG33191 -
CG34349 -
CG42324
Cyp6a17 Cyp6a17
meso18E meso18E
Msr-110 Msr-110
unc-119 unc-119
Biological process designation was determined from either direct GO
biological process terms or inferred from GO molecular function terms
curated from the Flybase database http://flybase.org/. Complete data for co-
upregulated genes, including Flybase ID, CCG number, gene symbol, gene
name, GO terms (function, process, and compartment), genetic interaction
partners, yeast and human orthologs, and fold change are provided as
Additional File 3.
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FHV-infected cells. This analysis allowed the determina-
tion of relative individual phospholipid species content
as a molar percentage of total recovered polar phospho-
lipids but also provided details on total acyl chain length
and saturation levels. As controls for these experiments
we used cells treated with miltefosine to decrease PC
levels or cells cultured with 1 mM oleic acid (cis-9-octa-
decenoic acid), which increases the production of phos-
pholipids with individual C18:1 acyl chains and hence
total sum acyl chain compositions of C36:2. Complete
detailed results from the ESI-MS/MS analyses are pro-
vided in Additional File 4. Control membrane extracts
from S2 cells contained predominantly PC and phospha-
tidylethanolamine (PE) as the primary phospholipids,
with the latter representing the majority (~40%) of all
phospholipids (Fig. 3B). Although PC is typically the
most prominent phospholipid in most eukaryotic cell
membranes, Diptera species such as Drosophila contain
relatively high levels of PE [29]. As expected, miltefosine
dramatically reduced PC content with compensatory
increases in the percentages of PE and phosphatidylino-
sitol (PI). In contrast, total cellular membranes from
FHV-infected S2 cells showed a trend towards an
increase in the molar percentage of PC and phosphati-
dylserine (PS) with an associated decrease in PE content,
but these differences were not statistically significant
( F i g .3 B ) .H o w e v e r ,w h e nw ea n a l y z e dP Cs p e c i e sb a s e d
on total acyl chain length or saturation level there were
modest but statistically significant changes in the per-
centage of PC molecules with total acyl chain lengths of
32 or 34 carbons (Fig. 3C) and 0, 1, or 2 total double
bonds (Fig. 3D), where FHV infection increased the frac-
tion of PC molecules with longer unsaturated acyl
chains. Furthermore, the selective increase in longer
unsaturated acyl chains in FHV-infected cells was seen
specifically with PC and not PE, PI, or PS (Fig. 3E and
data not shown). These quantitative lipid analysis results
suggested that FHV infection induces selective changes
in PC metabolism, and are consistent with the observa-
tion that FHV RNA replication complex activity in iso-
lated membrane fractions analyzed in vitro is
preferentially stimulated by phospholipids with increased
acyl chain length and decreased saturation [21].
Manipulation of glycerophospholipid metabolism gene
expression modulates FHV RNA replication in Drosophila
S2 cells
We next examined the potential functional significance
of lipid metabolism gene upregulation on FHV RNA
replication in S2 cells using a targeted genetic approach
that employed RNAi-mediated knockdown [17]. We
identified thirty-one cDNAs within the O’Farrell RNAi
collection [30] that were targeted toward genes involved
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Figure 2 FHV infection and replicon expression upregulate
partially overlapping sets of Drosophila genes. (A) Venn diagram
indicating the number of upregulated genes unique to FHV-infected
cells (white circle), unique to FHV replicon-expressing cells (grey
circle), or upregulated with both (black convergence). Total
numbers of genes are given within the indicated regions, and
complete lists and descriptions of genes are provided in Table 1
and as Additional Files 1, 2 and 3. Specific upregulated genes
involved in lipid metabolism, as identified by GO terms, are shown
by either their gene symbols or CG designations. (B) Semi-
quantitative RT-PCR validation of Cct1 and Cct2 mRNA upregulation
in Drosophila S2 cells infected with FHV. Decreasing amounts of
cDNA generated by RT with oligo-dT primers and equivalent
amounts of total RNA from mock (upper gel) or FHV-infected S2
cells (lower gel) were amplified with gene-specific primers for
Drosophila actin (Act5C), Cct1,o rCct2, and PCR products were
examined by agarose gel electrophoresis and ethidium bromide
staining. The expression level of the Act5C transcript in microarray
experiments was not significantly altered with FHV infection or
replicon expression. Densitometry analysis of PCR products
generated from cDNA dilutions that produced submaximal signals
showed that FHV infection induced 2.0 ± 0.2 and 2.3 ± 0.3 fold
increases in Cct1 and Cct2 mRNA levels, respectively, consistent with
quantitative microarray results (see Additional File 1). (C) Semi-
quantitative RT-PCR validation of Cct1 and Cct2 mRNA upregulation
in Drosophila S2 cells expressing an FHV replicon. RT-PCR was
performed as described above with total RNA from S2 cells
containing the control plasmid pS2F1fs (upper gel) or FHV replicon-
encoding plasmid pS2F1 (lower gel). Densitometry analysis of PCR
products as described above showed that FHV replicon expression
induced 1.9 ± 0.2 and 2.8 ± 0.9 fold increases in Cct1 and Cct2
mRNA levels, respectively, consistent with quantitative microarray
results (see Additional File 2).
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Page 5 of 16in glycerophospholipid metabolism in Drosophila cells,
generated 300-600 bp dsRNAs, and performed RNAi
knockdown experiments with infected S2 cells using
dsRNA targeted against FHV RNA1 and miltefosine as
p o s i t i v ec o n t r o l s( F i g .4 A ) .T oq u a n t i t a t eF H VR N A
replication, we used an optimized capture enzyme-
linked immunosorbant assay (ELISA) that detected pro-
tein B2, which is a viral protein only produced during
active RNA replication (see Fig. 1C). Although protein
B2 is an RNAi suppressor, it functions during the
assembly of RNAi-induced silencing complexes [31],
and therefore would have less impact on the activity of
functional silencing complexes formed during the 48 h
dsRNA incubation period prior to FHV infection. We
found that dsRNAs directed against five cellular genes,
Ace, Cct1, Cct2, fu12,a n dsan, all significantly sup-
pressed FHV RNA replication in infected S2 cells (Fig.
4A). Although the level of suppression was 20-40% with
individual knockdown of these five genes, the positive
control FHV dsRNA only reduced protein B2 levels by
~45%, suggesting that this medium throughput assay
p r o v i d e dac o n s e r v a t i v ee s t i m a t eo ft h ef u n c t i o n a l
impact of cellular glycerophospholipid metabolism gene
knockdown. The functions of Cct1 and Cct2 have been
described above. Ace encodes acetylcholine esterase [32],
fu12 encodes an enzyme with 1-acylglycerol-3-phos-
phate acyltransferase activity [33], and san also encodes
an enzyme with acyltransferase activity [34]. The
enzymes encoded by Cct1, Cct2, Ace, fu12,a n dsan are
all involved in PC synthesis, either directly or indirectly
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Figure 3 FHV infection and replicon expression modulate phospholipid levels in Drosophila S2 cells.( A )T o t a lP Cl e v e l si nS 2c e l l s
infected with FHV or treated with miltefosine (left graph) or expressing an FHV RNA1 replicon (right graph). Total PC levels were determined in
cells 24 h after infection, treatment, or replicon induction and are expressed relative to total cellular protein levels. (B) Phospholipid species
distribution in control S2 cells, cells infected with FHV, or cells treated with miltefosine or oleic acid. Relative phospholipid species content is
expressed as a molar percentage of total phospholipid content and was determined by ESI-MS/MS. (C) PC acyl chain length in mock, FHV-
infected, and oleic acid-treated S2 cells. Total PC chain length was determined by ESI-MS/MS and represents the total number of carbons from
both acyl chains. (D) PC acyl chain saturation in mock, FHV-infected, and oleic acid-treated S2 cells. Total number of C = C double bonds in PC
species was determined by ESI-MS/MS and represents the total number of double bonds in both acyl chains. The fraction of PC species with
greater than two double bonds was 0.5 to 1.5% for both mock and FHV-infected cells (see Additional File 4), and therefore these results were
not included in the graph. (E) PC, PE, and PI species with acyl chains containing a total of 34 carbons and 2 double bonds in mock and FHV-
infected S2 cells. P-value < 0.05* or 0.005**.
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Figure 4 RNAi-mediated knockdown of Drosophila genes involved in glycerophospholipid metabolism modulate FHV replication in S2
cells. (A) Medium throughput RNAi-based functional screen of select glycerophospholipid metabolism genes. Drosophila S2 cells were cultured
in 96-well plates, incubated with dsRNA targeting specific glycerophospholipid metabolism-related genes, positive control FHV RNA1, or negative
control LacZ for 48 h, infected with FHV, and harvested 18 h after infection. As an additional separate control, selected wells were treated with
50 μM miltefosine at the time of infection. FHV replication was assayed by protein B2 (PtnB2)-specific capture ELISA. Parallel MTT viability assays
demonstrated > 90% viability for all dsRNA- or miltefosine-treated samples compared to LacZ dsRNA-treated control (data not shown). Results
are expressed as the percentage of PtnB2 accumulation relative to LacZ dsRNA-treated control (hatched line). P-value < 0.05* or 0.005**. (B)
Schematic of eukaryotic glycerophospholipid synthesis pathways. The simplified biosynthetic pathways shown were adapted from the detailed
and comprehensive KEGG glycerophospholipid metabolism pathway available at http://www.genome.jp/kegg/. Drosophila genes with known or
hypothesized lipid biosynthetic functions are shown, and those identified as being functionally important for FHV RNA replication are boxed in
grey. The major eukaryotic glycerophospholipids are indicated in bold type: CL, cardiolipin; PA, phosphatidic acid; PC, phosphatidylcholine; PE,
phosphatidylethanolamine; PG, phosphatidylglycerol; PI, phosphatidylinositol; PS, phosphatidylserine. The essential precursor glycerol-3-phosphate
and important intermediates are shown in italics: DAG, diacylglycerol.
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Page 7 of 16(Fig. 4B). The main glycerophospholipids in the cell, PC
and PE, are synthesized through two metabolic path-
ways, the de novo synthesis pathway that uses PS as a
precursor for both, and the salvage or CDP pathway,
also referred to as the Kennedy pathway, which recycles
choline and ethanolamine to produce PC and PE,
respectively [35]. In higher eukaryotes the salvage or
CDP pathway of PC synthesis normally predominates,
where the conversion of phosphocholine to CDP-cho-
line, which is catalyzed by CTP:phosphocholine cytidy-
lyltransferases such as those encoded by Cct1 and Cct2,
is the rate limiting step [35]. Thus, we chose to focus
further on these two Drosophila glycerophospholipid
synthesis genes.
To verify the functional impact of Cct1 and Cct2
activity on FHV RNA replication in S2 cells, we gener-
ated alternative dsRNAs targeting different coding
regions of these two genes and repeated RNAi-mediated
knockdown experiments, including co-knockdown of
both Cct1 and Cct2 mRNA (Fig. 5). We validated knock-
down of Cct1 and Cct2 mRNA expression by RT-PCR,
where we obtained an approximate 80-90% gene-specific
reduction in steady state levels (Fig. 5A). Furthermore,
quantitative analysis demonstrated a 30-35% reduction
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Figure 5 Verification of Cct1 and Cct2 roles in modulating FHV replication in infected S2 cells. (A) RT-PCR validation of Cct1 or Cct2 RNAi-
mediated knockdown. Drosophila S2 cells were treated with dsRNAs specific for LacZ (lane 1), Cct1 (lane 2), Cct2 (lane 3), or both Cct1 and Cct2
(lane 4) for 72 h, and gene-specific mRNA expression was examined by semi-quantitative RT-PCR as described in Fig. 2, except that only results
from cDNA dilutions that produced submaximal signals are shown. (B) Total PC content in cells treated with the dsRNAs described above. PC
levels were determined as in Fig. 3. (C) Viability of cells treated with dsRNAs described above determined by MTT assay. (D) FHV RNA
accumulation in infected S2 cells after RNAi-mediated knockdown of Cct1, Cct2, or both. Mock-infected cells (lane 1), cells treated with the
indicated dsRNA as described above or FHV RNA1 as a positive control (lanes 2-6), or treated with 50 μM miltefosine (lane 7), were infected with
FHV and viral-specific RNAs or protein were analyzed by northern blotting or immunoblotting 12 h after infection, respectively. For viral RNA
analysis, blots for positive-sense (+) and negative-sense (-) genomic RNA1 and subgenomic (+)RNA3 are shown. The decrease in (+)RNA1
accumulation in Cct1 knockdown cells (lane 4) was not consistently seen in all experiments. Ribosomal RNA (rRNA) bands detected by ethidium
bromide staining are shown as loading controls. For protein analysis, blots for FHV protein A and the cellular loading control tubulin are shown.
(E) Quantitative data for genomic (+)RNA1 and (-)RNA1, subgenomic (+)RNA3, and protein A accumulation in S2 cells treated with the indicated
dsRNA or miltefosine after infection with FHV. Results are expressed as percentage of accumulation relative to LacZ dsRNA-treated control. P-
value < 0.05* or 0.005**.
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Page 8 of 16in total PC levels with individual knockdown of either
Cct1 or Cct2 mRNA, and a ~60% reduction with knock-
down of both genes (Fig. 5B). The incomplete knock-
down of Cct1 and Cct2 mRNA, the presence of a Cct-
independent de novo PC synthesis pathway (see Fig.
4B), and the essential role that PC plays in cellular
structure and metabolism all likely contributed to the
lack of synergistic suppression of total PC levels with an
RNAi-based approach that targeted one step in the bio-
synthetic pathway. We also examined cell viability by
MTT assay, as disruption of CTP:phosphocholine cyti-
dylyltransferase expression or function in mammalian
cells results in enhanced susceptibility to apoptosis
[36-38]. Individual knockdown of either Cct1 or Cct2
mRNA had no significant impact on cell viability,
whereas co-knockdown of both genes resulted in a
small but reproducible 15% reduction in cell viability as
measured by MTT assay (Fig. 5C). We infected S2 cells
with FHV after RNAi-mediated suppression of Cct1,
Cct2, or both genes, and measured viral RNA and pro-
tein accumulation at 12 h after infection. Downregula-
tion of either Cct1 or Cct2 individually suppressed FHV
subgenomic (+)RNA3 accumulation by ~30%, but did
not significantly reduce the accumulation of genomic
(+)RNA1, (-)RNA1, or protein A (Figs. 5D and 5E).
However, downregulation of both Cct1 and Cct2
resulted in a 40-65% reduction in the accumulation of
all viral products examined, similar to the levels of sup-
pression seen with the positive controls miltefosine and
dsRNA directly targeting FHV RNA1. Although we can-
not exclude the possibility that the small reduction in
cell viability with co-knockdown of both Cct1 and Cct2
(Fig. 5C) adversely affected viral RNA or protein accu-
mulation, potentially via apoptosis-mediated reduction
in synthesis or stability, published studies have demon-
strated that FHV replication is not sensitive to the anti-
viral effects of apoptosis induction in Drosophila cells
[39]. These results indicated that genetic or pharmacolo-
gic disruption of PC synthesis inhibited FHV RNA repli-
cation in infected S2 cells.
To further examine the functional impact of Cct1 and
Cct2 on FHV RNA replication in the absence of infec-
tious virus, we repeated experiments using RNAi-
mediated downregulation of these genes in S2 cells
expressing an RNA1 replicon (Fig. 6). We could not use
stably transfected cells for genetic knockdown experi-
ments, as the low level of FHV RNA replication in these
cells in the absence of copper sulfate induction resulted
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(rRNA) bands are shown as loading controls. The position of genomic (+)RNA1, which is barely detectable in transiently transfected S2 cells, is
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downregulation of cellular genes (data not shown).
Therefore, we used a transient transfection approach.
We treated S2 cells with dsRNAs for 48 h, transfected
cells with pS2F1 (see Fig. 1B) and control plasmid
pS2LacZ, and measured FHV RNA replication by north-
ern blotting and b-galactosidase activity by enzymatic
assay 18 h after induction. We used pS2LacZ as a trans-
fection control, as modulation of PC levels may influ-
ence transfection efficiency. Knockdown of either Cct1
or Cct2 suppressed FHV (+)RNA3 accumulation by 20-
40% in pS2F1-transfected cells, whereas knockdown of
both genes increased suppression to 65%, similar to
levels seen with control dsRNA targeted against FHV
RNA1 (Figs. 6A and 6B). We did not quantitate geno-
mic (+)RNA1 or protein A accumulation levels in trans-
fected cells, as these viral products accumulated to low
and almost undetectable levels in pS2F1-transfected
cells (Fig. 6A and data not shown), such that attempts
at quantitation would have been unreliable. Neverthe-
less, these results supported the conclusion that disrup-
tion of PC synthesis by genetic modulation of Cct1 or
Cct2 inhibited FHV RNA replication.
Finally, we examined whether disruption of Cct1 or
Cct2 expression directly suppressed FHV protein A
accumulation or membrane association (Fig. 7), as we
have previously demonstrated that cellular factors can
impact viral RNA polymerase production [17,22] and
hence facilitate an early step in RNA replication com-
plex assembly (see Fig. 1C). Although protein A levels
were decreased in FHV-infected cells with RNAi-
mediated downregulation of both genes (Figs. 5D and
5E), protein A accumulation int h es e t t i n go fi n f e c t i o u s
virus or an FHV replicon is directly linked to RNA
r e p l i c a t i o n( s e eF i g .1 C ) .T h u s ,w eu s e dap r o t e i nA
expression vector, called pS2FA-HA (Fig. 7A), which is
designed to optimize translation and prevent RNA
replication via modification of 5’ and 3’ untranslated
sequences that contain essential cis elements [17,22].
In contrast to the effects of Cct1-o rCct2-specific
dsRNAs on FHV RNA replication (Figs. 5 and 6),
knockdown of either gene had no effect on RNA poly-
merase accumulation in cells transfected with pS2FA-
HA (Fig. 7B), whereas dsRNAs against Hsp83 sup-
pressed polymerase accumulation by 60%, consistent
with published studies demonstrating the important
role of hsp90 chaperones in FHV protein A synthesis
[17,22]. Furthermore, knockdown of Cct1, Cct2,o r
both genes did not alter the ability of protein A to
associate with intracellular membranes, as determined
by differential centrifugation (Fig. 7C). These results
indicated that PC synthesis was important for FHV
RNA replication but not viral polymerase production
or membrane association.
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Figure 7 RNAi-mediated knockdown of Cct1 or Cct2 does not
modulate FHV protein A accumulation or membrane
association in S2 cells. (A) Schematic of FHV protein A expression
vector with C-terminal HA tag. The RNA template produced from
pS2FA-HA is optimized for translation by inclusion of a 5’ leader
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immunoblotting for protein A, the cytosolic protein tubulin, or the
membrane protein porin.
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Global approaches such as transcriptomic, proteomic,
and functional genomic analyses have provided impor-
tant clues to critical host-pathogen interactions that
influence virus replication and pathogenesis [40-47].
However, these approaches when used in isolation often
provide an overwhelming amount of information that
requires careful selection and validation. We have used
an alternative approach that incorporates more targeted
analyses including lipidomics to specifically examine the
role of glycerophospholipid metabolism in FHV RNA
replication. The results presented in this report further
support the well described crucial role that intracellular
membranes play in positive-strand RNA virus replica-
tion [3-5], but emphasize that cellular lipids are key
membrane constituents for this particular host-pathogen
interaction. Furthermore, this report provides new
details on the impact of specific lipid metabolism path-
ways on viral RNA replication, and in particular PC bio-
synthesis. The identification of specific lipid metabolism
pathways is an essential first step in the rationale design
of antiviral strategies that target cellular rather than
viral components. Indeed, the recognition that choles-
terol metabolism is important for hepatitis C virus repli-
cation in cultured cells [48,49] has led to direct clinical
trials using cholesterol synthesis inhibitors [50].
The observation that PC is important for FHV RNA
replication in cells is consistent with results published
almost twenty years ago, which demonstrated that phos-
pholipids enhance FHV RNA replication complex activ-
ity in isolated membrane fractions analyzed in vitro [21].
It also supports the hypothesis that one potential role
cellular membranes play in viral RNA replication is to
provide functional co-factors such as phospholipids for
optimal RNA polymerase activity, and is consistent with
published observations on the functional impact that
phospholipids have on Semliki Forest virus nsP1 methyl-
transferase activity [51]. The precise mechanism(s)
whereby phospholipids enhance FHV RNA replication
complex activity is unknown, and there are multiple
steps during process of viral RNA replication that could
be influenced by these cellular components (see Fig.
1C). Interestingly, the observation that individual knock-
down of Cct1 or Cct2 expression had an apparent pre-
ferential effect on subgenomic RNA3 production (Fig. 5)
suggests that this particular step may be especially sensi-
tive to cellular phospholipids. In addition to their poten-
tial roles as functional cofactors, membrane-resident
lipids may also play other roles during RNA replication,
such as providing a scaffold for replication complex tar-
geting and assembly. Indeed, we recently demonstrated
that FHV protein A is a lipid-binding protein with parti-
cular affinity for anionic phospholipids, including the
mitochondrial-specific phospholipid cardiolipin [14].
Interestingly, we could not detect a significant physical
interaction between FHV protein A and PC using in
vitro assays [14], suggesting that PC may influence pro-
tein A activity indirectly or interact via some as yet uni-
dentified intermediate protein or lipid.
Transcriptional array results suggested that FHV RNA
replication stimulated PC synthesis in part via Cct1 or
Cct2 upregulation, but the molecular mechanisms
whereby FHV modulates lipid biosynthesis are
unknown. One hypothesis is that FHV simply takes
advantage of the cellular stress response to virus infec-
tion that may induce changes in phospholipid metabo-
lism. However, published microarray results with
cultured S2 cells infected with various pathogens,
including viruses, bacteria, parasites, or fungi do not
demonstrate a consistent upregulation of glyceropho-
spholipid metabolism-related genes [44,47,52]. An alter-
native hypothesis is that FHV directly and specifically
modulates glycerophospholipid metabolism. Interest-
ingly, the enzyme encoded by Drosophila Cct1 is acti-
vated by cellular lipids, and in particular cardiolipin
[24], suggesting a potential link with the observed pro-
tein A-cardiolipin interaction [14]. Phosphatidic acid,
which represents the essential precursor in the synthesis
of all glycerophospholipids [35] (see also Fig. 4B), also
physically interacts with FHV protein A [14] and could
serve as a potential conduit for regulation. Although
these hypotheses are speculative and cannot directly
explain transcriptional upregulation, they are readily tes-
table with FHV using established in vitro and in vivo
systems.
We focused on PC for this report, but our results do
not exclude the potential important role of other cellu-
lar phospholipids in FHV RNA replication. Indeed, both
transcriptomic (Fig. 2A) and functional genetic (Fig. 4A)
analyses identified numerous additional candidate lipid
metabolism-associated genes linked to FHV RNA repli-
cation. Furthermore, the lipidomics analysis examined
total cellular membrane lipid content, whereas FHV
RNA replication complexes localize to outer mitochon-
drial membranes and induce dramatic morphological
and structural changes [11,15]. Although most glycero-
phospholipids, and in particular the highly abundant PC
and PE, are widely distributed in membranes throughout
the cell [29,53], detailed analyses of mitochondrial outer
membrane lipids may reveal interesting and potentially
more dramatic changes than we observed with the total
cellular lipid analyses. Experiments are currently in pro-
gress to isolate and examine mitochondrial and submi-
tochondrial fractions from cells with active FHV RNA
replication complexes using well established techniques
[54]. In addition, the observation that specific acyl chain
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cies were seen in FHV-infected cells suggests that parti-
cular lipid changes apart from the phospholipid head
group also may play important roles in viral RNA repli-
cation. This is consistent with the demonstration that
brome mosaic virus RNA replication is suppressed in
yeast with a deletion of the enzyme Δ9 fatty acid desa-
turase [55]. FHV replicates robustly in Saccharomyces
cerevisiae [12,56,57], and preliminary results suggest that
FHV RNA replication in yeast is also influenced by
alterations in PC metabolism (K. Stapleford and D.
Miller, unpublished results). Phospholipid metabolism
pathways and their regulation have been well studied in
yeast [58], and therefore this genetically tractable host
provides an excellent companion for parallel studies
with Drosophila cells to further examine the impact of
lipid metabolism on FHV RNA replication.
Conclusions
In this study we demonstrate through a combination of
complementary targeted and global analyses that glycer-
ophospholipids, and in particular PC, play an important
role in FHV RNA replication. These results enhance our
understanding of the essential function that cellular
membranes have in facilitating positive-strand RNA
virus replication, and suggest that modulating cellular
phospholipid synthesis may represent a novel approach
for targeted antiviral development.
Methods
Cells and virus
Drosophila S2 cells were cultured in Schneider’s Droso-
phila media (SDM) and transfected with inducible
expression plasmids as previously described [17].
Sucrose gradient-purified FHV [11] was used for all
infection experiments.
Plasmids, antibodies, and chemicals
Standard molecular biology procedures were used for all
cloning steps. The FHV RNA1 replicon expression plas-
mid pS2F1 (Fig. 1B), the protein A expression plasmid
pS2FA-HA, and the control plasmid pS2LacZ have been
previously described [17]. The control plasmid pS2F1fs,
which contains an early frameshifting mutation in the
protein A coding region (Fig. 1B) and hence will not
produce a functional cis replicon transcript [6,12], was
generated by cloning the ScaI/BsrGI fragment from
pF1fs [6] into the MscI/Acc65I sites of pMT-V5/HisA
(Invitrogen, Carlsbad, CA). Rabbit polyclonal antibodies
against FHV protein A have been previously described
[11], and antibodies against FHV protein B2 were gener-
ously provided by Paul Ahlquist (University of Wiscon-
sin-Madison). Rabbit polyclonal antibodies against the
hemagglutinin (HA) epitope tag or the voltage-
dependent anion channel porin were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA) or Affinity
Bioreagents (Golden, CO), respectively, while monoclo-
nal antibodies against tubulin were purchased from the
Developmental Studies Hybridoma Bank (University of
Iowa, Iowa City, IA). All secondary reagents for ELISA
and immunoblot analyses were purchased from Jackson
Immunoresearch (West Grove, PA). The CTP:phospho-
choline cytidyltransferase inhibitor miltefosine (1-hexa-
decylphosphorylcholine) was purchased from
Calbiochem (San Diego, CA) and stored as a 100 mM
stock solution in dimethylsulfoxide at -20°C. Oleic acid
(cis-9-octadecenoic acid) was purchased from Sigma (St.
Louis, MO) and stored as an undiluted stock solution at
-20°C.
FHV infection, replicon induction, and total RNA isolation
Cells were either infected with FHV at a multiplicity of
infection of 10 as previously described [11] and har-
vested at 12 to 24 h after infection, or transiently trans-
fected with pS2F1 and pS2LacZ as previously described
[17] and harvested at 18 h after induction with 0.5 mM
copper sulfate. For microarray and phospholipid ana-
lyses, S2 cells stably transfected with pS2F1 or pS2F1fs
were induced with 1 mM copper sulfate and harvested
at 18 h after induction. Total RNA was isolated using
TRIzol reagent (Invitrogen) per the manufacturer’s
instruction. For microarray and RT-PCR analyses, RNA
was further processed by digestion with RQ1 DNAse
and subsequent purification with RNAsy columns (Qia-
gen, Valencia, CA). Total RNA purity, integrity, and
concentration were checked by spectrophotometry and
agarose gel electrophoresis, and samples were stored at
-80°C until analysis.
Affymetrix microarray data acquisition and analysis
Affymetrix Drosophila Genome 1.0 or 2.0 microarrays
were used for FHV infection or replicon experiments,
respectively, and biotinylated amplified cRNAs were
produced using Affymetrix GeneChip target labelling
kits per the manufacturer’s instructions. Microarrays
were scanned with an Affymetrix Scanner 3000, and
complete original data files for all microarray experi-
ments have been deposited in the Gene Expression
Omnibus (GEO) database http://www.ncbi.nlm.nih.gov/
geo/ under the accession number GSE15469.
Genomatix ChipInspector software package was used
for primary microarray data analyses. This program
uses a single probe method with an enhanced statistics
package based on a SAM algorithm [59] that incorpo-
rates a t-test with a permuted artificial background to
reduce false-positives. The following parameters were
chosen to identify sets of up- or downregulated tran-
scripts: (i) false-discovery rate of 1%; (ii) three probe
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trol. Similar results were obtained when microarray data
were analyzed with the Affymetrix package of Biocon-
ductor [60]. The FlyBase database (FB2008_09; http://
flybase.org/) was used to identify Gene Ontology (GO)
terms, genetic interaction partners, and yeast-human
orthologs for Drosophila genes identified in the micro-
array analyses.
Semiquantitative RT-PCR validation
First-strand cDNA synthesis was completed with equal
amount of total RNA using oligo-dT primers and the
Superscript II First Strand synthesis kit (Invitrogen) per
the manufacturer’s instructions. Ten-fold dilutions of
cDNA were used for PCR reactions with gene-specific
primer sets (Table 2) under the following conditions:
200 nM primers, 58°C annealing temperature, and 30
cycles. RT-PCR products were analyzed by agarose gel
electrophoresis and ethidium bromide staining.
Phospholipid analysis
Total PC content was determined using a modified
phospholipase D-based enzymatic method initially devel-
oped for measurement of plasma PC levels [27]. Briefly,
S2 cells were pelleted at 1,000 × g for 5 min at 4°C,
washed twice with Tris-buffered saline (TBS) (100 mM
sodium chloride, 50 mM Tris, pH 7.2), lysed with 1%
Triton X-100, and incubated with reaction buffer con-
taining 50 mM Tris (pH 7.2), 0.64 M calcium chloride,
0.73 M N-ethyl-N-(2-hydroxy-3-sulfopropyl)-3,5-
dimethoxyanaline, 0.73 M 4-aminoantipyrine, 120 U/ml
PC-specific phospholipase D, 0.5 U/ml choline oxidase,
and 20 U/ml peroxidase. Reactions were incubated at
37°C for 2 h and the absorbance at 595 nm was mea-
sured using a FLUOstar Omega microplate reader
(BMG Labtech, Durham, NC). Quantitative PC
concentrations were calculated using a standard curve
generated with purified PC. Parallel total protein con-
centrations were determined with cell lysates prepared
using TBS and 1% n-octyl-b-D-glucopuranoside and
BioRad total protein reagent with bovine serum albumin
as the standard. For analysis of individual cellular phos-
pholipids, S2 cells were pelleted, washed twice with
TBS, and lipids were extracted with chloroform:metha-
nol using the method of Bligh and Dyer [61]. Final
extract samples were dried under vacuum and analyzed
for polar lipid content by ESI-MS/MS at the Kansas
Lipidomics Research Center http://www.k-state.edu/
lipid/lipidomics/index.htm.
dsRNA production and RNAi induction
The O’Farrell RNAi library was purchased from the
Drosophila Genome Research Center (DGRC). This col-
lection contains 300-600 bp double-stranded cDNAs
corresponding to greater than 7,000 individual phylo-
genetically conserved Drosophila genes [30], which can
all be amplified by PCR using a common oligonucleo-
tide primer (S2-RNAi-T7) that contains a GC-rich linker
and T7 RNA polymerase promoter (Table 2). PCR pro-
ducts were generated using Eppendorf Mastermix with
200 nM primers, annealing temperature of 62°C, and 40
cycles. If no product was obtained after the first amplifi-
cation, a second PCR was done using an aliquot of the
first reaction as a template. PCR products were analyzed
by non-denaturing gel electrophoresis and ethidium bro-
mide staining and purified using a PCR cleanup kit
(Promega) per the manufacturer’s instruction. To gener-
ate the cDNA templates for Cct1 and Cct2 validation
studies, candidate RNAi targets that differed from the
O’Farrell library constructs were identified using the E-
RNAi program [62]. To generate control FHV RNA1-
specific dsRNA we targeted nucleotides 40-735, which
include the initiator AUG codon. RT-PCR with gene-
specific primer sets that incorporated a T7 RNA poly-
merase promoter (Table 2) were used to generate PCR
templates for dsRNA generation. Control LacZ and
Hsp83 cDNAs were produced as previously described
[17].
RNAs were generated using a T7 Megascript kit
(Ambion) per the manufacturer’s instruction, purified
by phenol-chloroform extraction and isopropanol pre-
cipitation, and resuspended in RNAse-free water.
dsRNAs were generated by heating samples to 65°C for
30 min and cooling slowly to room temperature. Sam-
ples were analyzed by non-denaturing agarose gel elec-
trophoresis and ethidium bromide staining to ensure
the formation of properly sized dsRNA products, quan-
titated by spectrophotometry, and stored at -20°C until
used for RNAi studies. RNAi was induced in cultured
S2 cells as previously described [17]. Briefly, 10 μg
Table 2 Oligonucleotide sequences.
Name/
description
Sequence (5’ ! 3’)
Cct1-for *GAGATGGCCGAGAAGTTGAG
Cct1-rev *GGATTCCCTCGATTCTCACA
Cct2-for *ACTTGGGCCTGAGACTGCTA
Cct2-rev *CTTTCGGCATTCTGTCCATT
Act5C-for ATGTGTGACGAAGAAGTTGCT
Act5C-rev GTCCCAGTTGGTCACGATACC
FHV1-RNAi-for TAATACGACTCACTATAGGGATGACTCTAAAAGTTATTC
FHV1-RNAi-rev TAATACGACTCACTATAGGGTCTGCTAGCGATAAAC
S2-RNAi-T7 TAATACGACTCACTATAGGGAGACCACGGGCGGGT
The T7 RNA polymerase promoter is in bold italics type for FHV1 RNAi-for,
FHV1 RNAi-rev, and S2-RNAi-T7 oligonucleotides, and was also added to the 5’
end of the Cct1 and Cct2 oligonucleotides (asterisks) that were used to
generate dsRNAs.
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6 cells in 0.5 ml serum-free
SDM, incubated at 25°C for 1 h, 0.5 ml SDM with 20%
fetal bovine serum was added and cells were incubated
for an additional 48-72 h prior to FHV infection or
replicon transfection.
FHV RNA replication analyses
To facilitate the analysis of FHV RNA replication in a
medium throughput format, an FHV protein B2 cap-
ture ELISA was developed. FHV protein B2-specific
polyclonal antibodies for detection were purified from
rabbit antisera by Staphylococcus aureus protein A affi-
nity chromatography and biotinylated with 6-(biotina-
midocaproylamido)caproic acid N-hydroxysuccinimide
ester (Sigma) per the manufacturer’s instructions. For
capture antibodies, total immunoglobulins from FHV
protein B2 antisera were isolated by saturated ammo-
nium sulfate precipitation. Flexible microassay plates
were coated with 5 μg / m lc a p t u r ea n t i b o d yi np h o s -
phate-buffered saline (PBS) (100 mM sodium chloride,
50 mM sodium phosphate, pH 7.4) overnight at 4°C,
blocked with 1% non-fat milk, and S2 cell lysates in
PBS with 0.5% Triton X-100 were incubated in dupli-
cate wells for 2 h at room temperature. Plates were
washed extensively with TBS and 0.1% Tween 20,
incubated with 1.25 μg/ml biotinylated detection anti-
body followed by streptavidin-alkaline phosphatase.
Plates were developed with 1 mg/ml p-nitrophenyl
phosphate in 50 mM sodium carbonate buffer (pH
10.0) with 1 mM magnesium chloride and the absor-
b a n c ea t4 0 5n mw a sm e a s u r e dw i t ht h em i c r o p l a t e
reader described above. Initial optimization experi-
ments demonstrated a high sensitivity for this assay,
where lysates from less than ten S2 cells expressing a
pS2F1-based replicon produced a positive signal (data
not shown). Northern blot analyses for FHV-specific
RNAs, immunoblot analyses for protein A accumula-
tion, saponin-mediated permeabilization and differen-
tial centrifugation, and b-galactosidase assays were
done as previously described [17,22].
Viability assays
Viability assays were performed using 3- [4,5-
dimethylthizol-2-yl]-2,5-diphenyltetrazolium bromide
(MTT) as previously described [63].
Statistical analyses
Microarray statistical analyses are described above. For
additional statistical analyses a two-tailed t test assuming
equal variances was used and a p value of < 0.05 was
considered significant. All results are representative or a
composite of at least three independent experiments,
w h e r eq u a n t i t a t i v ed a t ar e p r e s e n tt h em e a n±s t a n d a r d
errors of the mean.
Additional file 1: Complete list of Drosophila genes up- or
downregulated in response to FHV infection. Drosophila genes that
showed significant up- or downregulation after FHV infection are listed
in an Excel spreadsheet and include fold change, Flybase ID, gene
symbol, gene name, and Gene Ontology (function, process, and
compartment) terms curated from the Flybase database http://flybase.
org/.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
183-S1.XLS]
Additional file 2: Complete list of Drosophila genes upregulated in
response to FHV replicon expression. Drosophila genes that showed
significant upregulation after FHV replicon expression are listed in an
Excel spreadsheet as described above for Additional File 1.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
183-S2.XLS]
Additional file 3: Complete list of Drosophila genes commonly
upregulated after both FHV infection and replicon expression.
Drosophila genes that showed significant upregulation after FHV infected
and replicon expression are listed in an Excel spreadsheet and include
fold change, Flybase ID, CCG number, gene symbol, gene name, Gene
Ontology (function, process, and compartment) terms, genetic
interaction partners, and yeast and human orthologs, curated from the
Flybase database http://flybase.org/.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
183-S3.XLS]
Additional file 4: Phospholipid levels in Drosophila S2 cells infected
with FHV treated with miltefosine or oleic acid. Levels of individual
lysoPC, PC, lysoPE, PE, PG, PI, PS, and PA species as determined by ESI-
MS/MS are expressed as the molar percentage of total phospholipids
content and listed in an Excel spreadsheet.
Click here for file
[http://www.biomedcentral.com/content/supplementary/1471-2164-11-
183-S4.XLS]
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